T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Radian Group
RDN
$4.92B
| $121M | 0.03% |
8,161,558
+777,410
| +11% | +$11.3M |
|
|
DCT
577
DELISTED
DCT Industrial Trust Inc.
DCT
| $121M | 0.03% |
3,679,003
+242,068
| +7% | +$7.64M |
|
|
IPCC
578
DELISTED
Infinity Property & Casualty C
IPCC
| $121M | 0.03% |
1,795,071
-1,500
| -0.1% | -$98.1K |
|
579
Target
TGT
$70.6B
| $120M | 0.03% |
2,067,836
-213,159
| -9% | -$12.5M |
|
580
Dorman Products
DORM
$3.95B
| $119M | 0.03% |
2,419,860
+11,630
| +0.5% | +$634K |
|
|
TRNX
581
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $119M | 0.03% |
5,102,990
+86,900
| +2% | +$1.81M |
|
582
NorthWestern Energy
NWE
$4.4B
| $119M | 0.03% |
2,286,005
+3,910
| +0.2% | +$188K |
|
583
Highwoods Properties
HIW
$3.51B
| $119M | 0.03% |
2,829,879
+69,207
| +3% | +$2.79M |
|
|
TIF
584
DELISTED
Tiffany & Co.
TIF
| $118M | 0.03% |
1,178,396
+326,730
| +38% | +$30.3M |
|
|
CLD
585
DELISTED
Cloud Peak Energy Inc
CLD
| $118M | 0.03% |
6,396,944
+591,334
| +10% | +$11.6M |
|
586
Yum! Brands
YUM
$41.2B
| $118M | 0.03% |
2,016,992
+852,333
| +73% | +$47.4M |
|
|
FITB
587
Fifth Third Bancorp
FITB
$52.5B
| $118M | 0.03% |
5,513,824
-1,082,135
| -16% | -$22.9M |
|
|
PMCS
588
DELISTED
P M C SIERRA INC
PMCS
| $118M | 0.03% |
15,468,690
-732,390
| -5% | -$5.3M |
|
589
Wintrust Financial
WTFC
$11B
| $117M | 0.03% |
2,552,100
+43,450
| +2% | +$1.97M |
|
|
WDR
590
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $117M | 0.03% |
1,868,039
-208,948
| -10% | -$13.5M |
|
|
ELME
591
Elme Communities
ELME
$144M
| $117M | 0.03% |
4,487,330
+31,800
| +0.7% | +$795K |
|
|
GAP
592
The Gap Inc
GAP
$7.34B
| $116M | 0.03% |
2,787,982
-196,800
| -7% | -$7.97M |
|
|
PE
593
DELISTED
PARSLEY ENERGY INC
PE
| $116M | 0.03% |
+4,811,810
| New | +$115M |
|
|
EPAY
594
DELISTED
Bottomline Technologies Inc
EPAY
| $116M | 0.03% |
3,868,380
+45,440
| +1% | +$1.4M |
|
595
Ares Capital
ARCC
$14.5B
| $116M | 0.03% |
6,476,100
-145,068
| -2% | -$2.49M |
|
596
McGrath RentCorp
MGRC
$2.94B
| $115M | 0.02% |
3,127,190
+5,030
| +0.2% | +$170K |
|
597
Core Laboratories
CLB
$569M
| $114M | 0.02% |
684,118
+159,687
| +30% | +$28.4M |
|
598
Equinix
EQIX
$106B
| $114M | 0.02% |
542,529
-975,562
| -64% | -$188M |
|
599
Abercrombie & Fitch
ANF
$4.84B
| $113M | 0.02% |
2,624,200
+573,700
| +28% | +$22.1M |
|
600
Louisiana-Pacific
LPX
$5.18B
| $113M | 0.02% |
7,528,620
+2,028,480
| +37% | +$30.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.